Metoclopramide Tablets, USP, 5 mg, 100 Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC: 51079-886-20.
Published November 4, 2026 · Recall initiated: October 6, 2026
Summary
FDA records drug Class II recall D-0075-2027, published November 4, 2026 and initiated October 6, 2026. Recalling firm: Safecor Health, LLC; Status: Ongoing; Lot: Lot # 3116509, Expiry: 07/31/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Manufacturer is recalling batches due to co-mingled tablet.
What to do
Voluntary: Firm initiated · E-Mail
Get an email if METOCLOPRAMIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- METOCLOPRAMIDE
- Manufacturer
- Safecor Health, LLC
- Distributor
- US Nationwide
- Lot
- Lot # 3116509, Expiry: 07/31/2027.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAbiraterone Acetate Tablets USP 500 mg, 60-count bottles, Rx only, Distributed by: Glenmark PharmaceuticalsNovember 4, 2026
- FDAOlmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Tablets 40 mg/10 mg/12.5mg, packaged as a) 30-countNovember 4, 2026
- FDAMetoclopramide Tablets, USP, 5 mg, 100 Tablets (10 x 10), Rx Only, Distributed by: American Health Packaging,October 21, 2026
- FDAMetoclopramide Tablets, USP, 5 mg, [100 or 500] Tablets per bottle, Rx Only, Manufactured for: TevaOctober 21, 2026
- FDAMetoclopramide Tablets, USP 10 mg, 100-count bottle, Rx only, Manufactured in Croatia by Pliva Hrvatska,July 2, 2025
- FDAMetoclopramide Injection USP, 10 mg/2mL (5 mg/mL) 2 mL single-use vial, Rx only, Teva Parenteral Medicines,August 25, 2021
Questions about this recall
Was Metoclopramide Tablets, USP, 5 mg, 100 Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC: 51079-886-20. recalled?
Yes. FDA published recall D-0075-2027 on November 4, 2026. Reported hazard: Manufacturer is recalling batches due to co-mingled tablet.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: METOCLOPRAMIDE.